VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.

Yuan, Long; Tatineni, Jahnavi; Mahoney, Kathleen M; Freeman, Gordon J.

Affiliation

Yuan L; Program in Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Tatineni J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Mahoney KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Electronic address: gordon_freeman@dfci.harvard.edu.

Trends Immunol ; 42(3): 209-227, 2021 03.

Article in En | MEDLINE | ID: mdl-33495077